Oldest pages

From OncoWiki
Jump to: navigation, search

Showing below up to 50 results in range #1 to #50.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. 5-FU + Cisplatin + RT‏‎ (02:17, 7 February 2012)
  2. 5-FU + Cisplatin + RT + Surgery‏‎ (02:17, 7 February 2012)
  3. 5-FU + Cisplatin + Vinblastine + RT + Surgery‏‎ (02:17, 7 February 2012)
  4. 5-FU + Cisplatin‏‎ (02:17, 7 February 2012)
  5. 5-FU + Cisplatin + Docetaxel‏‎ (02:17, 7 February 2012)
  6. 5-FU MitomycinC Radiation Therapy Wayne State Regimen‏‎ (02:17, 7 February 2012)
  7. ASHAP‏‎ (02:17, 7 February 2012)
  8. A-C-T‏‎ (02:17, 7 February 2012)
  9. ABDIC‏‎ (02:17, 7 February 2012)
  10. Acute Lymphoblastic Leukemia, Adult‏‎ (02:17, 7 February 2012)
  11. ABVD‏‎ (02:17, 7 February 2012)
  12. Acute Lymphoblastic Leukemia, Pediatric‏‎ (02:17, 7 February 2012)
  13. 5-FU + LV‏‎ (02:17, 7 February 2012)
  14. AC‏‎ (02:17, 7 February 2012)
  15. 5-FU + LV + Bevacizumab‏‎ (02:17, 7 February 2012)
  16. AD‏‎ (02:17, 7 February 2012)
  17. 5-FU + LV + Irinotecan‏‎ (02:17, 7 February 2012)
  18. ADE‏‎ (02:17, 7 February 2012)
  19. Adriamycin + Cisplatin‏‎ (02:17, 7 February 2012)
  20. 5-FU + LV + Mitomycin + Dipyridamole‏‎ (02:17, 7 February 2012)
  21. ADOC‏‎ (02:17, 7 February 2012)
  22. Adriamycin + Cisplatin + Paclitaxel‏‎ (02:17, 7 February 2012)
  23. 5-FU + LV + RT‏‎ (02:17, 7 February 2012)
  24. AI‏‎ (02:17, 7 February 2012)
  25. Alemtuzumab‏‎ (02:17, 7 February 2012)
  26. 5-FU + RT‏‎ (02:17, 7 February 2012)
  27. AIDA-PETHEMA Group‏‎ (02:17, 7 February 2012)
  28. 5-FU MitomycinC Radiation Therapy EORTC Regimen‏‎ (02:17, 7 February 2012)
  29. Bendamustine‏‎ (02:17, 7 February 2012)
  30. Brain Tumors Adult‏‎ (02:17, 7 February 2012)
  31. Anal Carcinoma‏‎ (02:17, 7 February 2012)
  32. Bendamustine + Rituximab‏‎ (02:17, 7 February 2012)
  33. Breast Cancer‏‎ (02:17, 7 February 2012)
  34. Arsenic Trioxide for APML, new cases‏‎ (02:17, 7 February 2012)
  35. Bevacizumab‏‎ (02:17, 7 February 2012)
  36. Arsenic Trioxide for relapsed APML‏‎ (02:17, 7 February 2012)
  37. Bevacizumab + Erlotinib‏‎ (02:17, 7 February 2012)
  38. CAF‏‎ (02:17, 7 February 2012)
  39. Azacitidine‏‎ (02:17, 7 February 2012)
  40. Bevacizumab + IFN‏‎ (02:17, 7 February 2012)
  41. CALGB 8811‏‎ (02:17, 7 February 2012)
  42. BiRD‏‎ (02:17, 7 February 2012)
  43. Bicalutamide‏‎ (02:17, 7 February 2012)
  44. BEP‏‎ (02:17, 7 February 2012)
  45. Bile Duct Cancer Extrahepatic‏‎ (02:17, 7 February 2012)
  46. BFM- 95 (German Protocol)‏‎ (02:17, 7 February 2012)
  47. Bladder Cancer‏‎ (02:17, 7 February 2012)
  48. BFM B-Cell‏‎ (02:17, 7 February 2012)
  49. Bonn protocol‏‎ (02:17, 7 February 2012)
  50. Alemtuzumab + Fludarabine‏‎ (02:17, 7 February 2012)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)